Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Compare cost structures of Index Funds and Target Date Funds to determine which option offers lower long-term expenses for retirement savers.
25,451 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Pinterest has shown strong quarterly results, yet the stock moves on mixed signals. This guide breaks down the what's...
DeFi hacks pummeled the market in April, sparking a bold security move from the Ethereum community. This article expl...
A Dallas mural of life-sized whales becomes the center of a $25 million lawsuit as World Cup organizers reportedly pa...
SSR Mining stock surged again as gold prices nudged higher and a strategic asset sale hinted at improved cash flow. T...
A prominent analyst argues SpaceX could surge, but practical hurdles and private-market realities temper the enthusia...
A landmark agreement between Apple and Broadcom signals a major shift in chip strategy and domestic manufacturing. Th...
Lucid Group has faced years of volatility, but Saudi backing and a clearer product roadmap could shift the odds. This...
StubHub's 2025 earnings narrative centers on the core marketplace while AI-driven product bets unfold in the backgrou...
WM Technology MAPS is weighing a pivotal year. This guide breaks down the Q4 2025 earnings, what technology (maps) 20...
A JPMorgan analyst forecasts looming oil shortages within weeks, drawing a sharp response from investors and fund man...
Oil markets are heating up as supply constraints tighten. Here are three solid stock ideas to consider before prices ...